Keyora Nutritional Neurology
This project serves as the comprehensive scientific repository and documentation hub for the Keyora Nutritional Neurology series, establishing a novel, evidence-based "Neuro-Engineering" framework.
Moving beyond the fragmented and symptomatic approach of traditional supplementation, this initiative systematically maps the multi-axis breakdown of human neurobiology under chronic high-performance stress—a pathology defined here as Stress-Induced Neurofunctional Disruption (SIND).
Our research investigates the intersecting failure points across the Hypothalamic-Pituitary-Adrenal (HPA) axis, neurotransmitter architecture (Serotonin, Dopamine, GABA), neuroplasticity (BDNF), mitochondrial energy metabolism, and sleep architecture (N3 Slow-Wave Sleep and Glymphatic clearance).
To counteract this systemic collapse, this repository details the mechanistic rationale, structural integrity, and clinical validation of the Keyora MoodFlow 8-in-1 Matrix. The matrix integrates specific, highly bioavailable neuro-modulators:
1. Standardized Ashwagandha (10% Withanolides):
The "Neuro-Endocrine Modulator" for cortisol normalization, sympathetic buffering, and BDNF-driven synaptic repair.
- Magnesium Glycinate:
The "Systemic Guardian" acting as an NMDA receptor antagonist to prevent glutamate excitotoxicity while optimizing Mg-ATP energetic output.
- 5-Hydroxytryptophan (5-HTP):
The direct biosynthetic precursor bypassing transport bottlenecks to restore central serotonin pools and stabilize mood.
- L-Theanine:
The "Alpha-Wave Inducer" promoting relaxed alertness and modulating the excitatory-inhibitory balance.
- B-Vitamin Complex (B1, B6, B12):
The metabolic coenzymes essential for myelin maintenance, TCA cycle energy production, and neurotransmitter biosynthesis.
2. Target Populations:
This intervention protocol is meticulously calibrated for individuals operating under sustained allostatic load, including high-cognitive-demand professionals, students navigating academic burnout, entrepreneurs, and peri-/menopausal women experiencing hormone-fluctuation-related neuro-friction.
3. Objective:
By enforcing the strict scientific axioms of Mechanism Before Formulation and Evidence Before Efficacy, this project aims to provide researchers, clinicians, and high-performance individuals with a transparent, peer-reviewed-backed architectural blueprint for restoring cognitive clarity, emotional resilience, and deep sleep without reliance on artificial stimulation or sedation.
1. The Philosophy of Neuro-Engineering
The Keyora framework is built upon the rejection of "biohacking" (cheating the biological system) in favor of Neuro-Engineering (optimizing the underlying architecture). We operate under a strict "Trust Algorithm" defined by three non-negotiable rules:
I. Mechanism Before Formulation:
We map the physiological failure point (e.g., HPA axis dysregulation, NMDA excitotoxicity) before selecting the molecular intervention.
II. Evidence Before Efficacy:
Every claim must be tethered to robust human Randomized Controlled Trials (RCTs) and transparent pharmacokinetics.
III. Transparency Over Secrecy:
Providing permanent DOIs and open-source mechanistic schematics to empower active clinical understanding.
2. The Core Pathology: Stress-Induced Neurofunctional Disruption (SIND)
Chronic stress in the modern phenotype is not merely a psychological burden; it is a systemic physiological collapse. SIND is characterized by:
I. The HPA Axis Hijack:
Chronic elevation of CRH/ACTH leading to toxic cortisol exposure ("Redline Idling").
II. Excitotoxicity & The Glutamate Storm:
Overactivation of NMDA receptors causing neuro-inflammation, calcium leakage, and "Wired but Tired" exhaustion.
III. The Serotonin Gap & Anhedonia:
Stress-induced diversion of tryptophan via the IDO pathway, resulting in serotonin depletion and dopamine receptor suppression.
IV. Glymphatic Failure:
The loss of Slow Wave Sleep (N3), preventing the clearance of neurotoxic metabolic waste.
3. The Architectural Solution: Keyora MoodFlow 8-in-1 Matrix
The MoodFlow protocol is a targeted neuro-psychiatric intervention designed to rebuild the biological hardware across four distinct functional axes:
Axis I: The Stress Buffer & Endocrine Reset (The Shield)
- Agent:
Ashwagandha (Standardized to 10% Withanolides)
- Mechanism:
Acts as a bi-directional adaptogen. It suppresses NF-κB inflammatory signaling, downregulates hypothalamic CRH expression, and reduces serum cortisol (up to 27.9% in clinical models). It acts as the "Commander" revoking the systemic alarm state.
Axis II: Excitatory-Inhibitory Balance (The Guard & The Tuner)
- Agent 1: Magnesium Glycinate
Mechanism: Functions as a voltage-dependent NMDA receptor blocker. It physically halts glutamate excitotoxicity. The glycine carrier independently acts as an inhibitory neurotransmitter, lowering core body temperature for sleep onset.
- Agent 2: L-Theanine
Mechanism: Shifts the cortex from anxiety-driven Beta-wave loops to the "relaxed alertness" of Alpha waves (8-13 Hz). Promotes GABA synthesis without sedation.
Axis III: The Biosynthetic Engine (The Fuel & The Architect)
- Agent 1: 5-HTP (5-Hydroxytryptophan)
Mechanism: Bypasses the Tryptophan Hydroxylase bottleneck and Blood-Brain Barrier transport competition to rapidly restore central serotonin pools.
- Agent 2: Vitamin B Complex (B1, B6, B12) & Vitamin D
Mechanism: B1 forces energy into the mitochondria via the TCA cycle (PDH coenzyme). B6 acts as the obligate cofactor for synthesizing Serotonin, GABA, and Dopamine. B12 clears neurotoxic homocysteine and maintains myelin integrity.
Axis IV: Neuroplasticity & Structural Repair
- Mechanism:
By lowering cortisol and buffering stress, the matrix allows for the upregulation of BDNF (Brain-Derived Neurotrophic Factor), driven strongly by Ashwagandha's withanolides, to reverse stress-induced hippocampal atrophy and restore synaptic density.
4. Target Clinical Phenotypes & Application
The Keyora framework categorizes SIND into specific human phenotypes to deploy precision protocols:
Phenotype I:
The "Wired but Tired" Executive. Requires NMDA antagonism (Magnesium) and Alpha-wave induction (L-Theanine) to break cognitive friction.
Phenotype II:
The Anhedonic High-Performer. Requires the "Resensitizing Matrix" (Ashwagandha + 5-HTP) to lower cortisol and reopen dopamine receptors, restoring the capacity to feel reward.
Phenotype III:
The "Junk Sleep" Sufferer. Requires HPA normalization and thermoregulatory drops (Glycine) to induce N3 Slow-Wave Sleep and activate the Glymphatic wash.
5. Methodology & Literature Base
This repository references over 70+ peer-reviewed academic papers. It bridges pharmacology, evolutionary biology, and neuro-metabolism to establish a new standard of care for cognitive sovereignty and emotional resilience.